Investor Relations

NYSE: TDOC +1.95 +5.74%
Volume: 1,522,462
20 minute delay December 15, 2017

News and Events

December 4, 2017
Teladoc Adds New Health System Clients, Achieving 2017 Growth in Excess of 100%
Comprehensive Telehealth Solution Tailored to Address Diverse Business Needs Fuels Expansion Teladoc , Inc. (NYSE:TDOC) the world’s largest and most trusted provider of virtual care delivery services, today announced record growth of greater than 100% in the hospital and health system market. The company now supports more than 200 hospitals, more than doubling its total in 2017. With the industry’s only fully configurable solution backed by comprehensive operational support, Teladoc is successfully partnering with facilities across the United States to address diverse needs including increased financial pressure, requirements to improve care outcomes and changing consumer expectations.
“Hospitals and health systems are under tremendous operating pressures, particularly as the industry shifts more toward value-based care and they seek to meet the care needs of new populations,” explained Alan Roga, M.D., president, health system market, Teladoc. “A significant strength and...
Read More
November 29, 2017
Teladoc Announces Pricing of Sale of Shares of Common Stock
Teladoc, Inc. (NYSE:TDOC) (“Teladoc”) today announced the pricing of the previously announced offering of shares of its common stock, which includes 3,454,000 shares offered by Teladoc and 830,000 shares offered by certain stockholders of Teladoc named in the preliminary prospectus supplement (the “selling stockholders”) at a price to the public of $35.00 per share. The offering is expected to close on or about December 4, 2017 , subject to customary closing conditions. In addition, the underwriters have a 30-day option to purchase up to an additional 642,600 shares of common stock from Teladoc .
The proceeds of the primary portion of the offering will be used by Teladoc to prepay borrowings outstanding under its senior secured term loan facility. The remaining proceeds of the primary portion of the offering will be used by Teladoc for working capital and general corporate purposes. Teladoc will not receive any proceeds from shares of common stock to be sold by the selling...
Read More